These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3098860)

  • 1. Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin.
    Grøndahl-Hansen J; Ralfkiaer E; Nielsen LS; Kristensen P; Frentz G; Danø K
    J Invest Dermatol; 1987 Jan; 88(1):28-32. PubMed ID: 3098860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo.
    Grøndahl-Hansen J; Lund LR; Ralfkiaer E; Ottevanger V; Danø K
    J Invest Dermatol; 1988 Jun; 90(6):790-5. PubMed ID: 3131440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies.
    Nielsen LS; Grøndahl-Hansen J; Andreasen PA; Skriver L; Zeuthen J; Danø K
    J Immunoassay; 1986; 7(3):209-28. PubMed ID: 3091639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis.
    Gissler HM; Frank R; Kramer MD
    Br J Dermatol; 1993 Jun; 128(6):612-8. PubMed ID: 7687853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator in psoriatic scales is of the tissue-type PA as identified by monoclonal antibodies.
    Grøndahl-Hansen J; Nielsen LS; Kristensen P; Grøndahl-Hansen V; Andreasen PA; Danø K
    Br J Dermatol; 1985 Sep; 113(3):257-63. PubMed ID: 3933538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal plasminogen activator is abnormal in cutaneous lesions.
    Jensen PJ; Baird J; Morioka S; Lessin S; Lazarus GS
    J Invest Dermatol; 1988 Jun; 90(6):777-82. PubMed ID: 3131439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activation in psoriasis.
    Lotti T; Bonan P; Panconesi E
    Acta Derm Venereol Suppl (Stockh); 1989; 146():36-8. PubMed ID: 2514542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localization of urokinase-type plasminogen activator in Sertoli cells and tissue-type plasminogen activator in spermatogenic cells in the rat seminiferous epithelium.
    Vihko KK; Kristensen P; Danø K; Parvinen M
    Dev Biol; 1988 Mar; 126(1):150-5. PubMed ID: 3125078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix.
    Grøndahl-Hansen J; Kirkeby LT; Ralfkiaer E; Kristensen P; Lund LR; Danø K
    Am J Pathol; 1989 Oct; 135(4):631-6. PubMed ID: 2508479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of plasminogen activator enzymes in psoriatic epidermis.
    Spiers EM; Lazarus GS; Lyons-Giordano B
    J Invest Dermatol; 1994 Mar; 102(3):333-8. PubMed ID: 8120416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factors, tissue and urokinase-type plasminogen activators in venous ulcers.
    Lagattolla NR; Stacey MC; Burnand KG; Gaffney PG
    Ann Cardiol Angeiol (Paris); 1995; 44(6):299-303. PubMed ID: 7574362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of urokinase-type plasminogen activator (u-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies.
    Darras V; Thienpont M; Stump DC; Collen D
    Thromb Haemost; 1986 Dec; 56(3):411-4. PubMed ID: 3105111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and localization of urokinase-type plasminogen activator in human NK-cells.
    Carpén O; Saksela O; Saksela E
    Int J Cancer; 1986 Sep; 38(3):355-60. PubMed ID: 3091511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microplate immunocapture assay for plasminogen activators and their specific inhibitors.
    Stephens R; Leung KC; Pöllänen J; Salonen EM; Vaheri A
    J Immunol Methods; 1987 Dec; 105(2):245-51. PubMed ID: 3121752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.
    Pöllänen J; Saksela O; Salonen EM; Andreasen P; Nielsen L; Danø K; Vaheri A
    J Cell Biol; 1987 Apr; 104(4):1085-96. PubMed ID: 3104349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urokinase type of plasminogen activator in cancer of digestive tracts.
    Nishino N; Aoki K; Tokura Y; Sakaguchi S; Takada Y; Takada A
    Thromb Res; 1988 May; 50(4):527-35. PubMed ID: 3137679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice.
    Declerck PJ; Verstreken M; Collen D
    Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
    Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
    Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder.
    Hasui Y; Suzumiya J; Marutsuka K; Sumiyoshi A; Hashida S; Ishikawa E
    Cancer Res; 1989 Feb; 49(4):1067-70. PubMed ID: 2492205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsoriatic therapies inhibit epidermal plasminogen activator activity.
    Lotti T; Bonan P; Cannarozzo G; Fedi AM; Panconesi E
    Int J Dermatol; 1990 Sep; 29(7):528-30. PubMed ID: 2121655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.